Esther Sauras-Colón

8PUBLICATIONS
48CO-AUTHORS
Tumour immunologyPredictive and prognostic markersCancer cell biologyInnate immunityPacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 04, 2026
Longitudinal evaluation of tumor-infiltrating lymphocyte scoring using automated region of interest registration in breast cancer.

|Nov 29, 2025
Histological Hyperspectral Breast Cancer Recurrence Database (HistologyHSI-BC Recurrence).

Laura Quintana-Quintana, Esther Sauras-Colón, Alessio Fiorin

|Nov 04, 2025
Cell populations in human breast cancers are molecularly and biologically distinct with age.

Adrienne Parsons, Esther Sauras Colón, Meghana Manjunath

|Mar 20, 2025
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design.

Kevin Groen, Roger Kuratli, Jannik Enkelmann

|Feb 09, 2022
CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients.

Carlos López, Ramón Bosch, Anna Korzynska

|Aug 12, 2021
How the variability between computer-assisted analysis procedures evaluating immune markers can influence patients' outcome prediction.

Marylène Lejeune, Benoît Plancoulaine, Nicolas Elie

Pageof 2

Frequent Collaborators

3 joint publications

Marylène Lejeune

2 joint publications

Ramon Bosch-Príncep

2 joint publications

Carlos López-Pablo

2 joint publications

Sílvia Reverté-Villarroya